Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2011 064 378.9 |
96 | EP file number | EAKZ | 11 78 1973.0 |
86 | WO file number | WAKZ | PCT/US2011/059233 |
97 | EP publication number | EPN | 2635677 |
87 | WO publication number | WPN | 2012061654 |
54 | Designation/title | TI | MODIFIZIERTE FACTOR IX PROTEINE UND DEREN VERWENDUNG |
51 | IPC main class | ICM (ICMV) | C12N 9/64 (2006.01) |
22 | DE application date | DAT | Nov 3, 2011 |
96 | EP application date | EAT | Nov 3, 2011 |
86 | WO application date | WAT | Nov 3, 2011 |
43 | Date of first publication | OT | May 10, 2012 |
| Date of publication of grant | PET | Jan 1, 2020 |
71/73 | Applicant/owner | INH | GC Biopharma Corp., Yongin-si, Gyeonggi-do, KR |
72 | Inventor | IN | MADISON, Edwin, L., San Francisco CA 94121, US; THANOS, Christopher, Tiburon CA 94920, US; BLOUSE, Grant, Ellsworth, Copenhagen S 2300, DK |
| Address for service | | Weickmann & Weickmann Patent- und Rechtsanwälte PartmbB, 81635 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 456298 P Nov 3, 2010
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002635677 Searchable text:
EP000002635677 Original document:
EP000002635677B1 Searchable text:
EP000002635677B1 Original document:
WO002012061654 Searchable text:
WO002012061654 |
43 | Date of first publication | EVT | May 10, 2012 |
| Date of the first transfer into DPMAregister | EREGT | Oct 25, 2013 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 20, 2025 (Show all update days)(Hide all update days)- Jul 20, 2025
- Status: changed
- Due date: deleted
- Procedures: Administrative procedure, Application deemed withdrawn due to non-payment of annual fee, 03.06.2025: new
- Apr 15, 2025
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 01.01.2020: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 01.01.2020: deleted
- Dec 11, 2024
- Procedures: Procedure relating to PCT application, Publication of PCT application, 10.05.2012: deleted
- Oct 25, 2013
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Apr 18, 2023 |
| Issue number | HN | 21 |
| Year | PJ | 2023 |
| Publication date | VT | May 25, 2023 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | GC Biopharma Corp., Yongin-si, Gyeonggi-do, KR |
71/73 | Previous applicant/owner | INHF | Catalyst Biosciences, Inc., South San Francisco, Calif., US |
| Date of update of the procedure | REGT | May 25, 2023 |